These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12202207)

  • 21. An Escherichia coli expression assay and screen for human immunodeficiency virus protease variants with decreased susceptibility to indinavir.
    Melnick L; Yang SS; Rossi R; Zepp C; Heefner D
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3256-65. PubMed ID: 9835523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid genetic selection of inhibitor-resistant protease mutants: clinically relevant and novel mutants of the HIV protease.
    Sices HJ; Leusink MD; Pacheco A; Kristie TM
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1249-55. PubMed ID: 11559424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequence variability of the HIV type 1 protease gene in thai patients experienced with antiretroviral therapy.
    Nukoolkarn S; Pongthapisith V; Panyim S; Leelamanit W
    AIDS Res Hum Retroviruses; 2004 Dec; 20(12):1368-72. PubMed ID: 15650431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
    Lefebvre E; Schiffer CA
    AIDS Rev; 2008; 10(3):131-42. PubMed ID: 18820715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural insights into the South African HIV-1 subtype C protease: impact of hinge region dynamics and flap flexibility in drug resistance.
    Naicker P; Achilonu I; Fanucchi S; Fernandes M; Ibrahim MA; Dirr HW; Soliman ME; Sayed Y
    J Biomol Struct Dyn; 2013 Dec; 31(12):1370-80. PubMed ID: 23140382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients.
    Torti C; Quiros-Roldan E; Monno L; Patroni A; Saracino A; Angarano G; Tinelli C; Lo Caputo S; Tirelli V; Mazzotta F; Carosi G; ;
    J Med Virol; 2004 Sep; 74(1):29-33. PubMed ID: 15258965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A molecular dynamics study comparing a wild-type with a multiple drug resistant HIV protease: differences in flap and aspartate 25 cavity dimensions.
    Seibold SA; Cukier RI
    Proteins; 2007 Nov; 69(3):551-65. PubMed ID: 17623840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro development of resistance to human immunodeficiency virus protease inhibitor GW640385.
    Yates PJ; Hazen R; St Clair M; Boone L; Tisdale M; Elston RC
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1092-5. PubMed ID: 16495277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection of resistance in protease inhibitor-experienced, human immunodeficiency virus type 1-infected subjects failing lopinavir- and ritonavir-based therapy: mutation patterns and baseline correlates.
    Mo H; King MS; King K; Molla A; Brun S; Kempf DJ
    J Virol; 2005 Mar; 79(6):3329-38. PubMed ID: 15731227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes.
    Holguín A; Paxinos E; Hertogs K; Womac C; Soriano V
    J Clin Virol; 2004 Nov; 31(3):215-20. PubMed ID: 15465415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of HIV-1 protease inhibitor resistance using a protein-inhibitor flexible docking approach.
    Jenwitheesuk E; Samudrala R
    Antivir Ther; 2005; 10(1):157-66. PubMed ID: 15751773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accessory mutations balance the marginal stability of the HIV-1 protease in drug resistance.
    Weikl TR; Hemmateenejad B
    Proteins; 2020 Mar; 88(3):476-484. PubMed ID: 31599014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates.
    Gonzalez LM; Santos AF; Abecasis AB; Van Laethem K; Soares EA; Deforche K; Tanuri A; Camacho R; Vandamme AM; Soares MA
    J Antimicrob Chemother; 2008 Jun; 61(6):1201-4. PubMed ID: 18356151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The HIV type 1 protease L10I minor mutation decreases replication capacity and confers resistance to protease inhibitors.
    Flor-Parra F; Pérez-Pulido AJ; Pachón J; Pérez-Romero P
    AIDS Res Hum Retroviruses; 2011 Jan; 27(1):65-70. PubMed ID: 21142921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms in HIV-1 subtype C proteases and the potential impact on protease inhibitors.
    Bessong PO
    Trop Med Int Health; 2008 Feb; 13(2):144-51. PubMed ID: 18304259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of HIV type 1 drug resistance mutations and phenotypic resistance profile on virologic response to salvage therapy.
    Ross L; Liao Q; Gao H; Pham S; Tolson J; Hertogs K; Larder B; Saag MS
    AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1379-85. PubMed ID: 11679150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of protease genotype and phenotype in HIV-1 infected patients exposed to more than one protease inhibitor.
    Gianotti N; Tambussi G; Boeri E; Lazzarin A
    J Biol Regul Homeost Agents; 2001; 15(2):166-9. PubMed ID: 11501975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late Domain.
    Martins AN; Waheed AA; Ablan SD; Huang W; Newton A; Petropoulos CJ; Brindeiro RD; Freed EO
    J Virol; 2016 Jan; 90(2):768-79. PubMed ID: 26512081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low accumulation of L90M in protease from subtype F HIV-1 with resistance to protease inhibitors is caused by the L89M polymorphism.
    Calazans A; Brindeiro R; Brindeiro P; Verli H; Arruda MB; Gonzalez LM; Guimaraes JA; Diaz RS; Antunes OA; Tanuri A
    J Infect Dis; 2005 Jun; 191(11):1961-70. PubMed ID: 15871131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidrug resistance to HIV-1 protease inhibition requires cooperative coupling between distal mutations.
    Ohtaka H; Schön A; Freire E
    Biochemistry; 2003 Nov; 42(46):13659-66. PubMed ID: 14622012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.